NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models
Michael Rugaard Jensen(Novartis (Switzerland)), Patrick Chêne(Novartis (Switzerland))
Cited by 224
Related Papers
Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue
|BMC Chemical Biology|2009|81
Effect of the acylation of TEAD4 on its interaction with co‐activators YAP and TAZ
|Protein Science|2017|69